Walter E. DeWolf
Impact in
- Microbiology top 2%
- Antimicrobial Peptides and Activities
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Metabolism, Diabetes, and Cancer 4
- Cell death mechanisms and regulation 4
-
- Antimicrobial agents and applications 6
- Co-authors
- Lawrence I. Kruse (15 shared papers)Paul M. Keller (12 shared papers)Dennis Lee (7 shared papers)David Payne (6 shared papers)Paula J. Goodhart (4 shared papers)Mark Nuttall (4 shared papers)Vern L. Schramm (4 shared papers)Stephen Rittenhouse (5 shared papers)
- Journals
- Journal of Medicinal Chemistry (11 papers)Biochemistry (7 papers)Journal of Biological Chemistry (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Walter E. DeWolf
51 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 118
- Microbiology 176
- Molecular Medicine 132
- Organic Chemistry 615
- Molecular Biology 1.0k
- Biochemistry 80
Countries citing papers authored by Walter E. DeWolf
This map shows the geographic impact of Walter E. DeWolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter E. DeWolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter E. DeWolf more than expected).
Fields of papers citing papers by Walter E. DeWolf
This network shows the impact of papers produced by Walter E. DeWolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter E. DeWolf. The network helps show where Walter E. DeWolf may publish in the future.
Co-authors
The 25 scholars most cited alongside Walter E. DeWolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 145 | |
| 2 | 2003 | 134 | |
| 3 | 2001 | 110 | |
| 4 | 2001 | 110 | |
| 5 | 2003 | 99 | |
| 6 | 1999 | 94 | |
| 7 | 2002 | 91 | |
| 8 | Renal cell carcinoma: recent progress and future directions. | 1997 | 86 |
| 9 | 2002 | 84 | |
| 10 | 2000 | 79 | |
| 11 | 1988 | 56 | |
| 12 | 2001 | 52 | |
| 13 | ARRY-520, a novel KSP inhibitor with potent activity in hematological and taxane-resistant tumor models. | 2009 | 51 |
| 14 | 1979 | 47 | |
| 15 | 1987 | 47 | |
| 16 | 1988 | 46 | |
| 17 | 1986 | 44 | |
| 18 | 1986 | 44 | |
| 19 | 1990 | 42 | |
| 20 | 1987 | 36 |
About Walter E. DeWolf
Walter E. DeWolf is a scholar working on Molecular Biology, Organic Chemistry, Physiology, Biochemistry and Microbiology, having authored 51 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antimicrobial agents and applications (6 papers), Biochemical Acid Research Studies (6 papers), Antimicrobial Peptides and Activities (6 papers), Pancreatic function and diabetes (5 papers), Metabolism, Diabetes, and Cancer (4 papers), Cell death mechanisms and regulation (4 papers), Neonatal Health and Biochemistry (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). The work is most often cited by research in Microbiology (176 citations), Molecular Medicine (132 citations), Organic Chemistry (615 citations), Molecular Biology (1.0k citations) and Biochemistry (80 citations). Walter E. DeWolf has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Lawrence I. Kruse, Paul M. Keller, Dennis Lee, David Payne, Paula J. Goodhart, Mark Nuttall, Vern L. Schramm, Stephen Rittenhouse, Terrance Moore and William F. Huffman. Their work appears in journals such as Journal of Medicinal Chemistry, Biochemistry, Journal of Biological Chemistry, Bioorganic & Medicinal Chemistry Letters and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.